Xenon Pharmaceuticals XENE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's free cash flow?
- Xenon Pharmaceuticals (XENE) reported free cash flow of -$89.03M in Q1 2026.
- How has Xenon Pharmaceuticals's free cash flow changed year-over-year?
- Xenon Pharmaceuticals's free cash flow decreased by 44.3% year-over-year, from -$61.7M to -$89.03M.
- What is the long-term trend for Xenon Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's free cash flow has grown at a 40.6% compound annual growth rate (CAGR), from -$71.55M to -$279.92M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.